The mutations in LRRK2 that are associated with aberrant kinase activity is a common and important inherited mutation linked to PD, where a series of kinase inhibitor molecules have been identified (Lesage and Brice, 2009, Taymans and Greggio, 2016). The gene discussed is LRRK2; the disease is Parkinson disease.